FDA STATE_REFERRAL_LETTER - Lynn Oaks Compounding Pharmacy - April 05, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This STATE REFERRAL LETTER record concerns Lynn Oaks Compounding Pharmacy, with an inspection on April 5, 2022, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Lynn Oaks Compounding Pharmacy
Inspection Date: April 5, 2022
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Steven E. Porter (Program Division Director)
Joshua Kent Miles
Andrew K. Haack (Compliance Officer)
Anne Sodergren

Open in Dashboard

ID · 2beb905f-e81e-47e7-95a1-9d349dc91a73

Violation Codes2

21 CFR 20.64(d)(3)21 CFR 20.88

Full citation text and observation details available on the Dashboard.